Globus Medical stock forecast
Globus Medical (GMED) Stock Forecast & Price Target
GMED Analyst Ratings
GMED Stock 12 Month Forecast
Average Price Target
Mex$1,691▲(9.13% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Vik Chopra | BMO Capital | Mex$1,742→Mex$1,446 | hold | -6.72%Downside | Downgraded | 11/06/26 | ||
| Larry Biegelsen | Wells Fargo | Mex$1,835→Mex$1,854 | buy | 19.59%Upside | Assigned | 11/06/26 | ||
| Matthew O'Brien | Piper Sandler | Mex$1,854 | buy | 19.59%Upside | Reiterated | 11/06/26 | ||
| Caitlin Roberts | Canaccord Genuity | Mex$2,132→Mex$1,946 | buy | 25.57%Upside | Reiterated | 11/06/26 | ||
| Richard Newitter | Truist Financial | Mex$1,854→Mex$1,668 | buy | 7.63%Upside | Reiterated | 11/06/26 | ||
| Travis Steed | Bank of America Securities | ― | buy | ― | Reiterated | 11/06/26 | ||
| Kendall Au | RBC Capital | Mex$1,576 | buy | 1.65%Upside | Reiterated | 11/05/26 | ||
| Thomas Stephan | Stifel Nicolaus | Mex$1,417→Mex$1,576 | hold | 1.65%Upside | Reiterated | 10/07/26 | ||
| Ryan Zimmerman | BTIG | ― | hold | ― | Reiterated | 09/18/26 | ||
| Keith Hinton | Freedom Capital Markets | Mex$1,613 | hold | 4.04%Upside | Reiterated | 08/27/26 | ||
| David Saxon | Needham | Mex$2,169 | buy | 39.92%Upside | Reiterated | 08/07/26 | ||
| Mathew Blackman | TD Cowen | Mex$2,132 | buy | 37.53%Upside | Reiterated | 08/06/26 | ||
| Patrick Wood | UBS | Mex$1,520 | hold | -1.94%Downside | Initiated | 07/28/26 | ||
| Matt Miksic | Barclays | Mex$2,280 | buy | 47.10%Upside | Reiterated | 05/11/26 | ||
| Matthew Taylor | Jefferies | Mex$1,946→Mex$2,132 | buy | 37.53%Upside | Reiterated | 01/08/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Vik ChopraBMO Capital | HoldDowngradedMex$1,742→Mex$1,446 | 11/06/26 | -6.72%Downside | ||
| Larry BiegelsenWells Fargo | BuyAssignedMex$1,835→Mex$1,854 | 11/06/26 | 19.59%Upside | ||
| Matthew O'BrienPiper Sandler | BuyReiteratedMex$1,854 | 11/06/26 | 19.59%Upside | ||
| Caitlin RobertsCanaccord Genuity | BuyReiteratedMex$2,132→Mex$1,946 | 11/06/26 | 25.57%Upside | ||
| Richard NewitterTruist Financial | BuyReiteratedMex$1,854→Mex$1,668 | 11/06/26 | 7.63%Upside | ||
| Travis SteedBank of America Securities | BuyReiterated | 11/06/26 | ― | ||
| Kendall AuRBC Capital | BuyReiteratedMex$1,576 | 11/05/26 | 1.65%Upside | ||
| Thomas StephanStifel Nicolaus | HoldReiteratedMex$1,417→Mex$1,576 | 10/07/26 | 1.65%Upside | ||
| Ryan ZimmermanBTIG | HoldReiterated | 09/18/26 | ― | ||
| Keith HintonFreedom Capital Markets | HoldReiteratedMex$1,613 | 08/27/26 | 4.04%Upside | ||
| David SaxonNeedham | BuyReiteratedMex$2,169 | 08/07/26 | 39.92%Upside | ||
| Mathew BlackmanTD Cowen | BuyReiteratedMex$2,132 | 08/06/26 | 37.53%Upside | ||
| Patrick WoodUBS | HoldInitiatedMex$1,520 | 07/28/26 | -1.94%Downside | ||
| Matt MiksicBarclays | BuyReiteratedMex$2,280 | 05/11/26 | 47.10%Upside | ||
| Matthew TaylorJefferies | BuyReiteratedMex$1,946→Mex$2,132 | 01/08/26 | 37.53%Upside |
Best Analysts Covering Globus Medical
Copying Matt Miksic's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.98% per trade.
Copying Matt Miksic's trades and holding each position for 1 Year would result in 59.38% of your transactions generating a profit, with an average return of +11.61% per trade.
Copying Matt Miksic's trades and holding each position for 2 Years would result in 68.75% of your transactions generating a profit, with an average return of +18.38% per trade.
GMED Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 0 | 0 | 0 | 0 |
| Buy | 12 | 18 | 15 | 13 | 7 |
| Hold | 5 | 8 | 8 | 6 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 19 | 26 | 23 | 19 | 10 |
In the current month, GMED has received 7 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. GMED average Analyst price target in the past 3 months is 1,691.44.
GMED Financial Forecast
GMED Earnings Forecast
Next quarter’s earnings estimate for GMED is MXN 23.98 with a range of MXN 22.88 to MXN 24.55. The previous quarter’s EPS was MXN 22.88. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
GMED Sales Forecast
Next quarter’s sales forecast for GMED is MXN 14.57B with a range of MXN 14.38B to MXN 15.88B. The previous quarter’s sales results were MXN 14.21B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

